Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
RNA Drugs market report explains the definition, types, applications, major countries, and major players of the RNA Drugs market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Pfizer
Abbott Laboratories
Benitec Biopharma
Roche
Senesco
Alnylam Pharmaceuticals
Tekmira
Gradalis
Silence Therapeutics
Arrowhead Pharmaceuticals
RXi
Silenseed
Sanofi-Aventis
Quark
Dicerna
Calimmune Inc
By Type:
siRNA
ASO
miRNA
Nucleic Acid Aptamers
By End-User:
Cancer
Diabetes
Tuberculosis
Cardiovascular Diseases
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global RNA Drugs Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 RNA Drugs Outlook to 2028- Original Forecasts
-
2.2 RNA Drugs Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term RNA Drugs Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global RNA Drugs Market- Recent Developments
-
6.1 RNA Drugs Market News and Developments
-
6.2 RNA Drugs Market Deals Landscape
7 RNA Drugs Raw Materials and Cost Structure Analysis
-
7.1 RNA Drugs Key Raw Materials
-
7.2 RNA Drugs Price Trend of Key Raw Materials
-
7.3 RNA Drugs Key Suppliers of Raw Materials
-
7.4 RNA Drugs Market Concentration Rate of Raw Materials
-
7.5 RNA Drugs Cost Structure Analysis
-
7.5.1 RNA Drugs Raw Materials Analysis
-
7.5.2 RNA Drugs Labor Cost Analysis
-
7.5.3 RNA Drugs Manufacturing Expenses Analysis
8 Global RNA Drugs Import and Export Analysis (Top 10 Countries)
-
8.1 Global RNA Drugs Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global RNA Drugs Export by Region (Top 10 Countries) (2017-2028)
9 Global RNA Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global RNA Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global siRNA Consumption and Growth Rate (2017-2022)
-
9.1.2 Global ASO Consumption and Growth Rate (2017-2022)
-
9.1.3 Global miRNA Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Nucleic Acid Aptamers Consumption and Growth Rate (2017-2022)
-
9.2 Global RNA Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Diabetes Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Tuberculosis Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise RNA Drugs Market Analysis and Outlook till 2022
-
10.1 Global RNA Drugs Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States RNA Drugs Consumption (2017-2022)
-
10.2.2 Canada RNA Drugs Consumption (2017-2022)
-
10.2.3 Mexico RNA Drugs Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany RNA Drugs Consumption (2017-2022)
-
10.3.2 UK RNA Drugs Consumption (2017-2022)
-
10.3.3 Spain RNA Drugs Consumption (2017-2022)
-
10.3.4 Belgium RNA Drugs Consumption (2017-2022)
-
10.3.5 France RNA Drugs Consumption (2017-2022)
-
10.3.6 Italy RNA Drugs Consumption (2017-2022)
-
10.3.7 Denmark RNA Drugs Consumption (2017-2022)
-
10.3.8 Finland RNA Drugs Consumption (2017-2022)
-
10.3.9 Norway RNA Drugs Consumption (2017-2022)
-
10.3.10 Sweden RNA Drugs Consumption (2017-2022)
-
10.3.11 Poland RNA Drugs Consumption (2017-2022)
-
10.3.12 Russia RNA Drugs Consumption (2017-2022)
-
10.3.13 Turkey RNA Drugs Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China RNA Drugs Consumption (2017-2022)
-
10.4.2 Japan RNA Drugs Consumption (2017-2022)
-
10.4.3 India RNA Drugs Consumption (2017-2022)
-
10.4.4 South Korea RNA Drugs Consumption (2017-2022)
-
10.4.5 Pakistan RNA Drugs Consumption (2017-2022)
-
10.4.6 Bangladesh RNA Drugs Consumption (2017-2022)
-
10.4.7 Indonesia RNA Drugs Consumption (2017-2022)
-
10.4.8 Thailand RNA Drugs Consumption (2017-2022)
-
10.4.9 Singapore RNA Drugs Consumption (2017-2022)
-
10.4.10 Malaysia RNA Drugs Consumption (2017-2022)
-
10.4.11 Philippines RNA Drugs Consumption (2017-2022)
-
10.4.12 Vietnam RNA Drugs Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil RNA Drugs Consumption (2017-2022)
-
10.5.2 Colombia RNA Drugs Consumption (2017-2022)
-
10.5.3 Chile RNA Drugs Consumption (2017-2022)
-
10.5.4 Argentina RNA Drugs Consumption (2017-2022)
-
10.5.5 Venezuela RNA Drugs Consumption (2017-2022)
-
10.5.6 Peru RNA Drugs Consumption (2017-2022)
-
10.5.7 Puerto Rico RNA Drugs Consumption (2017-2022)
-
10.5.8 Ecuador RNA Drugs Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain RNA Drugs Consumption (2017-2022)
-
10.6.2 Kuwait RNA Drugs Consumption (2017-2022)
-
10.6.3 Oman RNA Drugs Consumption (2017-2022)
-
10.6.4 Qatar RNA Drugs Consumption (2017-2022)
-
10.6.5 Saudi Arabia RNA Drugs Consumption (2017-2022)
-
10.6.6 United Arab Emirates RNA Drugs Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria RNA Drugs Consumption (2017-2022)
-
10.7.2 South Africa RNA Drugs Consumption (2017-2022)
-
10.7.3 Egypt RNA Drugs Consumption (2017-2022)
-
10.7.4 Algeria RNA Drugs Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia RNA Drugs Consumption (2017-2022)
-
10.8.2 New Zealand RNA Drugs Consumption (2017-2022)
11 Global RNA Drugs Competitive Analysis
-
11.1 Pfizer
-
11.1.1 Pfizer Company Details
-
11.1.2 Pfizer RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Pfizer RNA Drugs Main Business and Markets Served
-
11.1.4 Pfizer RNA Drugs Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Abbott Laboratories
-
11.2.1 Abbott Laboratories Company Details
-
11.2.2 Abbott Laboratories RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Abbott Laboratories RNA Drugs Main Business and Markets Served
-
11.2.4 Abbott Laboratories RNA Drugs Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Benitec Biopharma
-
11.3.1 Benitec Biopharma Company Details
-
11.3.2 Benitec Biopharma RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Benitec Biopharma RNA Drugs Main Business and Markets Served
-
11.3.4 Benitec Biopharma RNA Drugs Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Roche
-
11.4.1 Roche Company Details
-
11.4.2 Roche RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Roche RNA Drugs Main Business and Markets Served
-
11.4.4 Roche RNA Drugs Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Senesco
-
11.5.1 Senesco Company Details
-
11.5.2 Senesco RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Senesco RNA Drugs Main Business and Markets Served
-
11.5.4 Senesco RNA Drugs Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Alnylam Pharmaceuticals
-
11.6.1 Alnylam Pharmaceuticals Company Details
-
11.6.2 Alnylam Pharmaceuticals RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Alnylam Pharmaceuticals RNA Drugs Main Business and Markets Served
-
11.6.4 Alnylam Pharmaceuticals RNA Drugs Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Tekmira
-
11.7.1 Tekmira Company Details
-
11.7.2 Tekmira RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Tekmira RNA Drugs Main Business and Markets Served
-
11.7.4 Tekmira RNA Drugs Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Gradalis
-
11.8.1 Gradalis Company Details
-
11.8.2 Gradalis RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Gradalis RNA Drugs Main Business and Markets Served
-
11.8.4 Gradalis RNA Drugs Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Silence Therapeutics
-
11.9.1 Silence Therapeutics Company Details
-
11.9.2 Silence Therapeutics RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Silence Therapeutics RNA Drugs Main Business and Markets Served
-
11.9.4 Silence Therapeutics RNA Drugs Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Arrowhead Pharmaceuticals
-
11.10.1 Arrowhead Pharmaceuticals Company Details
-
11.10.2 Arrowhead Pharmaceuticals RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Arrowhead Pharmaceuticals RNA Drugs Main Business and Markets Served
-
11.10.4 Arrowhead Pharmaceuticals RNA Drugs Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 RXi
-
11.11.1 RXi Company Details
-
11.11.2 RXi RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 RXi RNA Drugs Main Business and Markets Served
-
11.11.4 RXi RNA Drugs Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Silenseed
-
11.12.1 Silenseed Company Details
-
11.12.2 Silenseed RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Silenseed RNA Drugs Main Business and Markets Served
-
11.12.4 Silenseed RNA Drugs Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Sanofi-Aventis
-
11.13.1 Sanofi-Aventis Company Details
-
11.13.2 Sanofi-Aventis RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Sanofi-Aventis RNA Drugs Main Business and Markets Served
-
11.13.4 Sanofi-Aventis RNA Drugs Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Quark
-
11.14.1 Quark Company Details
-
11.14.2 Quark RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Quark RNA Drugs Main Business and Markets Served
-
11.14.4 Quark RNA Drugs Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Dicerna
-
11.15.1 Dicerna Company Details
-
11.15.2 Dicerna RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Dicerna RNA Drugs Main Business and Markets Served
-
11.15.4 Dicerna RNA Drugs Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 Calimmune Inc
-
11.16.1 Calimmune Inc Company Details
-
11.16.2 Calimmune Inc RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 Calimmune Inc RNA Drugs Main Business and Markets Served
-
11.16.4 Calimmune Inc RNA Drugs Product Portfolio
-
11.16.5 Recent Research and Development Strategies
12 Global RNA Drugs Market Outlook by Types and Applications to 2028
-
12.1 Global RNA Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global siRNA Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global ASO Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global miRNA Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Nucleic Acid Aptamers Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global RNA Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Tuberculosis Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)
-
12.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise RNA Drugs Market Analysis and Outlook to 2028
-
13.1 Global RNA Drugs Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States RNA Drugs Consumption Forecast (2022-2028)
-
13.2.2 Canada RNA Drugs Consumption Forecast (2022-2028)
-
13.2.3 Mexico RNA Drugs Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany RNA Drugs Consumption Forecast (2022-2028)
-
13.3.2 UK RNA Drugs Consumption Forecast (2022-2028)
-
13.3.3 Spain RNA Drugs Consumption Forecast (2022-2028)
-
13.3.4 Belgium RNA Drugs Consumption Forecast (2022-2028)
-
13.3.5 France RNA Drugs Consumption Forecast (2022-2028)
-
13.3.6 Italy RNA Drugs Consumption Forecast (2022-2028)
-
13.3.7 Denmark RNA Drugs Consumption Forecast (2022-2028)
-
13.3.8 Finland RNA Drugs Consumption Forecast (2022-2028)
-
13.3.9 Norway RNA Drugs Consumption Forecast (2022-2028)
-
13.3.10 Sweden RNA Drugs Consumption Forecast (2022-2028)
-
13.3.11 Poland RNA Drugs Consumption Forecast (2022-2028)
-
13.3.12 Russia RNA Drugs Consumption Forecast (2022-2028)
-
13.3.13 Turkey RNA Drugs Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China RNA Drugs Consumption Forecast (2022-2028)
-
13.4.2 Japan RNA Drugs Consumption Forecast (2022-2028)
-
13.4.3 India RNA Drugs Consumption Forecast (2022-2028)
-
13.4.4 South Korea RNA Drugs Consumption Forecast (2022-2028)
-
13.4.5 Pakistan RNA Drugs Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh RNA Drugs Consumption Forecast (2022-2028)
-
13.4.7 Indonesia RNA Drugs Consumption Forecast (2022-2028)
-
13.4.8 Thailand RNA Drugs Consumption Forecast (2022-2028)
-
13.4.9 Singapore RNA Drugs Consumption Forecast (2022-2028)
-
13.4.10 Malaysia RNA Drugs Consumption Forecast (2022-2028)
-
13.4.11 Philippines RNA Drugs Consumption Forecast (2022-2028)
-
13.4.12 Vietnam RNA Drugs Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil RNA Drugs Consumption Forecast (2022-2028)
-
13.5.2 Colombia RNA Drugs Consumption Forecast (2022-2028)
-
13.5.3 Chile RNA Drugs Consumption Forecast (2022-2028)
-
13.5.4 Argentina RNA Drugs Consumption Forecast (2022-2028)
-
13.5.5 Venezuela RNA Drugs Consumption Forecast (2022-2028)
-
13.5.6 Peru RNA Drugs Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico RNA Drugs Consumption Forecast (2022-2028)
-
13.5.8 Ecuador RNA Drugs Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain RNA Drugs Consumption Forecast (2022-2028)
-
13.6.2 Kuwait RNA Drugs Consumption Forecast (2022-2028)
-
13.6.3 Oman RNA Drugs Consumption Forecast (2022-2028)
-
13.6.4 Qatar RNA Drugs Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia RNA Drugs Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates RNA Drugs Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria RNA Drugs Consumption Forecast (2022-2028)
-
13.7.2 South Africa RNA Drugs Consumption Forecast (2022-2028)
-
13.7.3 Egypt RNA Drugs Consumption Forecast (2022-2028)
-
13.7.4 Algeria RNA Drugs Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia RNA Drugs Consumption Forecast (2022-2028)
-
13.8.2 New Zealand RNA Drugs Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of RNA Drugs
-
Figure of RNA Drugs Picture
-
Table Global RNA Drugs Import by Region (Top 10 Countries) (2017-2028)
-
Table Global RNA Drugs Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global siRNA Consumption and Growth Rate (2017-2022)
-
Figure Global ASO Consumption and Growth Rate (2017-2022)
-
Figure Global miRNA Consumption and Growth Rate (2017-2022)
-
Figure Global Nucleic Acid Aptamers Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Global Tuberculosis Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global RNA Drugs Consumption by Country (2017-2022)
-
Table North America RNA Drugs Consumption by Country (2017-2022)
-
Figure United States RNA Drugs Consumption and Growth Rate (2017-2022)
-
Figure Canada RNA Drugs Consumption and Growth Rate (2017-2022)
-
Figure Mexico RNA Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe RNA Drugs Consumption by Country (2017-2022)
-
Figure Germany RNA Drugs Consumption and Growth Rate (2017-2022)
-
Figure UK RNA Drugs Consumption and Growth Rate (2017-2022)
-
Figure Spain RNA Drugs Consumption and Growth Rate (2017-2022)
-
Figure Belgium RNA Drugs Consumption and Growth Rate (2017-2022)
-
Figure France RNA Drugs Consumption and Growth Rate (2017-2022)
-
Figure Italy RNA Drugs Consumption and Growth Rate (2017-2022)
-
Figure Denmark RNA Drugs Consumption and Growth Rate (2017-2022)
-
Figure Finland RNA Drugs Consumption and Growth Rate (2017-2022)
-
Figure Norway RNA Drugs Consumption and Growth Rate (2017-2022)
-
Figure Sweden RNA Drugs Consumption and Growth Rate (2017-2022)
-
Figure Poland RNA Drugs Consumption and Growth Rate (2017-2022)
-
Figure Russia RNA Drugs Consumption and Growth Rate (2017-2022)
-
Figure Turkey RNA Drugs Consumption and Growth Rate (2017-2022)
-
Table APAC RNA Drugs Consumption by Country (2017-2022)
-
Figure China RNA Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan RNA Drugs Consumption and Growth Rate (2017-2022)
-
Figure India RNA Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea RNA Drugs Consumption and Growth Rate (2017-2022)
-
Figure Pakistan RNA Drugs Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh RNA Drugs Consumption and Growth Rate (2017-2022)
-
Figure Indonesia RNA Drugs Consumption and Growth Rate (2017-2022)
-
Figure Thailand RNA Drugs Consumption and Growth Rate (2017-2022)
-
Figure Singapore RNA Drugs Consumption and Growth Rate (2017-2022)
-
Figure Malaysia RNA Drugs Consumption and Growth Rate (2017-2022)
-
Figure Philippines RNA Drugs Consumption and Growth Rate (2017-2022)
-
Figure Vietnam RNA Drugs Consumption and Growth Rate (2017-2022)
-
Table South America RNA Drugs Consumption by Country (2017-2022)
-
Figure Brazil RNA Drugs Consumption and Growth Rate (2017-2022)
-
Figure Colombia RNA Drugs Consumption and Growth Rate (2017-2022)
-
Figure Chile RNA Drugs Consumption and Growth Rate (2017-2022)
-
Figure Argentina RNA Drugs Consumption and Growth Rate (2017-2022)
-
Figure Venezuela RNA Drugs Consumption and Growth Rate (2017-2022)
-
Figure Peru RNA Drugs Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico RNA Drugs Consumption and Growth Rate (2017-2022)
-
Figure Ecuador RNA Drugs Consumption and Growth Rate (2017-2022)
-
Table GCC RNA Drugs Consumption by Country (2017-2022)
-
Figure Bahrain RNA Drugs Consumption and Growth Rate (2017-2022)
-
Figure Kuwait RNA Drugs Consumption and Growth Rate (2017-2022)
-
Figure Oman RNA Drugs Consumption and Growth Rate (2017-2022)
-
Figure Qatar RNA Drugs Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia RNA Drugs Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates RNA Drugs Consumption and Growth Rate (2017-2022)
-
Table Africa RNA Drugs Consumption by Country (2017-2022)
-
Figure Nigeria RNA Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Africa RNA Drugs Consumption and Growth Rate (2017-2022)
-
Figure Egypt RNA Drugs Consumption and Growth Rate (2017-2022)
-
Figure Algeria RNA Drugs Consumption and Growth Rate (2017-2022)
-
Table Oceania RNA Drugs Consumption by Country (2017-2022)
-
Figure Australia RNA Drugs Consumption and Growth Rate (2017-2022)
-
Figure New Zealand RNA Drugs Consumption and Growth Rate (2017-2022)
-
Table Pfizer Company Details
-
Table Pfizer RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer RNA Drugs Main Business and Markets Served
-
Table Pfizer RNA Drugs Product Portfolio
-
Table Abbott Laboratories Company Details
-
Table Abbott Laboratories RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories RNA Drugs Main Business and Markets Served
-
Table Abbott Laboratories RNA Drugs Product Portfolio
-
Table Benitec Biopharma Company Details
-
Table Benitec Biopharma RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Benitec Biopharma RNA Drugs Main Business and Markets Served
-
Table Benitec Biopharma RNA Drugs Product Portfolio
-
Table Roche Company Details
-
Table Roche RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche RNA Drugs Main Business and Markets Served
-
Table Roche RNA Drugs Product Portfolio
-
Table Senesco Company Details
-
Table Senesco RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Senesco RNA Drugs Main Business and Markets Served
-
Table Senesco RNA Drugs Product Portfolio
-
Table Alnylam Pharmaceuticals Company Details
-
Table Alnylam Pharmaceuticals RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alnylam Pharmaceuticals RNA Drugs Main Business and Markets Served
-
Table Alnylam Pharmaceuticals RNA Drugs Product Portfolio
-
Table Tekmira Company Details
-
Table Tekmira RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tekmira RNA Drugs Main Business and Markets Served
-
Table Tekmira RNA Drugs Product Portfolio
-
Table Gradalis Company Details
-
Table Gradalis RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gradalis RNA Drugs Main Business and Markets Served
-
Table Gradalis RNA Drugs Product Portfolio
-
Table Silence Therapeutics Company Details
-
Table Silence Therapeutics RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Silence Therapeutics RNA Drugs Main Business and Markets Served
-
Table Silence Therapeutics RNA Drugs Product Portfolio
-
Table Arrowhead Pharmaceuticals Company Details
-
Table Arrowhead Pharmaceuticals RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Arrowhead Pharmaceuticals RNA Drugs Main Business and Markets Served
-
Table Arrowhead Pharmaceuticals RNA Drugs Product Portfolio
-
Table RXi Company Details
-
Table RXi RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table RXi RNA Drugs Main Business and Markets Served
-
Table RXi RNA Drugs Product Portfolio
-
Table Silenseed Company Details
-
Table Silenseed RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Silenseed RNA Drugs Main Business and Markets Served
-
Table Silenseed RNA Drugs Product Portfolio
-
Table Sanofi-Aventis Company Details
-
Table Sanofi-Aventis RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi-Aventis RNA Drugs Main Business and Markets Served
-
Table Sanofi-Aventis RNA Drugs Product Portfolio
-
Table Quark Company Details
-
Table Quark RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Quark RNA Drugs Main Business and Markets Served
-
Table Quark RNA Drugs Product Portfolio
-
Table Dicerna Company Details
-
Table Dicerna RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dicerna RNA Drugs Main Business and Markets Served
-
Table Dicerna RNA Drugs Product Portfolio
-
Table Calimmune Inc Company Details
-
Table Calimmune Inc RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Calimmune Inc RNA Drugs Main Business and Markets Served
-
Table Calimmune Inc RNA Drugs Product Portfolio
-
Figure Global siRNA Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ASO Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global miRNA Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Nucleic Acid Aptamers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tuberculosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global RNA Drugs Consumption Forecast by Country (2022-2028)
-
Table North America RNA Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe RNA Drugs Consumption Forecast by Country (2022-2028)
-
Figure Germany RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure France RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC RNA Drugs Consumption Forecast by Country (2022-2028)
-
Figure China RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table South America RNA Drugs Consumption Forecast by Country (2022-2028)
-
Figure Brazil RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC RNA Drugs Consumption Forecast by Country (2022-2028)
-
Figure Bahrain RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa RNA Drugs Consumption Forecast by Country (2022-2028)
-
Figure Nigeria RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania RNA Drugs Consumption Forecast by Country (2022-2028)
-
Figure Australia RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
